Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1420408

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1420408

Intravenous Infusion Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

The latest report from Fairfield Market Research reveals that global sales for the Intravenous Infusion Pumps Market in 2024 reached US$6 billion. Projected to grow at a CAGR of 11% from 2024 to 2031, the market is expected to reach US$12.5 billion. The absolute dollar opportunity for the market, driven by increased demand for intravenous infusion pumps in healthcare facilities like hospitals and nursing homes.

What will be the growth prospects of the Intravenous Infusion Pumps Market?

Chronic illnesses, responsible for 80% of deaths in low- and middle-income nations, encompass cardiovascular diseases, stroke, cancer, chronic respiratory diseases, and diabetes. Cardiovascular disease is the leading global cause of mortality, as per the World Health Organization. The incidence of cancer worldwide has sharply risen to 18.1 million cases in 2018. This surge in chronic illnesses, including cardiovascular disease and cancer, has driven the demand for intravenous infusion pumps. The increased disease burden also heightens the risk of drug errors, necessitating safer and more standardized delivery methods. The development of smart intravenous infusion pumps, or next-generation pumps, with computerized features aims to minimize dosage errors and enhance error-free medical care, contributing to market growth.

Which Region is projected to Offer the Largest Opportunity for Intravenous Infusion Pumps Market?

The Asia Pacific is anticipated to experience the fastest growth in Intravenous Infusion Pumps Market revenue. The region's increasing aging population, coupled with a growing middle class, is expected to drive demand in the coming years. UNFPA research indicates that the APAC region's aging population is rapidly expanding, with one in four individuals projected to be over 60 by 2050, reaching a total population of nearly 1.3 billion.

Country-wise Analysis

The United States leads the global Intravenous Infusion Pumps Market and is projected to reach US$5.1 billion by 2031, driven by favorable factors such as reimbursement policies and technological advancements. The country's growing geriatric population is a key driver, with projections indicating an increase from 52 million in 2018 to nearly 95 million by 2060. North America is expected to hold a significant market share due to the prevalence of chronic illnesses, accounting for over 75% of healthcare expenses. The adoption of technologically advanced products, awareness of modern intravenous infusion pumps, and a well-established healthcare infrastructure contribute to the market's growth.

Key Companies Profiled

  • BAXTER INTERNATIONAL
  • B. BRAUN MELSUNGEN AG
  • MEDTRONIC
  • MICREL MEDICAL DEVICES SA
  • BOSTON SCIENTIFIC CORPORATION
  • CAREFUSION CORPORATION
  • FRESENIUS KABI
  • SMITHS MEDICAL

Market Segments Covered in Intravenous Infusion Pumps Industry Analysis

By Infusion Pumps Type

  • Volumetric Infusion Pumps
  • Insulin Infusion Pumps
  • Syringe Infusion Pumps
  • Enteral Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Implantable Infusion Pumps
  • Other Infusion Pumps Types

By Disease Indication

  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics /Neonatology
  • Hematology
  • Other Disease Indications

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Intravenous Infusion Pumps Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Intravenous Infusion Pumps Market Outlook, 2018 - 2031

  • 3.1. Global Intravenous Infusion Pumps Market Outlook, by Infusion Pumps, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Volumetric Infusion Pumps
      • 3.1.1.2. Insulin Infusion Pumps
      • 3.1.1.3. Syringe Infusion Pumps
      • 3.1.1.4. Enteral Infusion Pumps
      • 3.1.1.5. Ambulatory Infusion Pumps
      • 3.1.1.6. Patient-Controlled Analgesia Infusion Pumps
      • 3.1.1.7. Implantable Infusion Pumps
      • 3.1.1.8. Other Infusion Pumps Types
  • 3.2. Global Intravenous Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Chemotherapy
      • 3.2.1.2. Diabetes
      • 3.2.1.3. Gastroenterology
      • 3.2.1.4. Analgesia/Pain Management
      • 3.2.1.5. Pediatrics /Neonatology
      • 3.2.1.6. Hematology
      • 3.2.1.7. Other Disease Indications
  • 3.3. Global Intravenous Infusion Pumps Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Intravenous Infusion Pumps Market Outlook, 2018 - 2031

  • 4.1. North America Intravenous Infusion Pumps Market Outlook, by Infusion Pumps, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Volumetric Infusion Pumps
      • 4.1.1.2. Insulin Infusion Pumps
      • 4.1.1.3. Syringe Infusion Pumps
      • 4.1.1.4. Enteral Infusion Pumps
      • 4.1.1.5. Ambulatory Infusion Pumps
      • 4.1.1.6. Patient-Controlled Analgesia Infusion Pumps
      • 4.1.1.7. Implantable Infusion Pumps
      • 4.1.1.8. Other Infusion Pumps Types
  • 4.2. North America Intravenous Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Chemotherapy
      • 4.2.1.2. Diabetes
      • 4.2.1.3. Gastroenterology
      • 4.2.1.4. Analgesia/Pain Management
      • 4.2.1.5. Pediatrics /Neonatology
      • 4.2.1.6. Hematology
      • 4.2.1.7. Other Disease Indications
  • 4.3. North America Intravenous Infusion Pumps Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Intravenous Infusion Pumps Market Outlook, 2018 - 2031

  • 5.1. Europe Intravenous Infusion Pumps Market Outlook, by Infusion Pumps, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Volumetric Infusion Pumps
      • 5.1.1.2. Insulin Infusion Pumps
      • 5.1.1.3. Syringe Infusion Pumps
      • 5.1.1.4. Enteral Infusion Pumps
      • 5.1.1.5. Ambulatory Infusion Pumps
      • 5.1.1.6. Patient-Controlled Analgesia Infusion Pumps
      • 5.1.1.7. Implantable Infusion Pumps
      • 5.1.1.8. Other Infusion Pumps Types
  • 5.2. Europe Intravenous Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Chemotherapy
      • 5.2.1.2. Diabetes
      • 5.2.1.3. Gastroenterology
      • 5.2.1.4. Analgesia/Pain Management
      • 5.2.1.5. Pediatrics /Neonatology
      • 5.2.1.6. Hematology
      • 5.2.1.7. Other Disease Indications
  • 5.3. Europe Intravenous Infusion Pumps Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Intravenous Infusion Pumps Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Intravenous Infusion Pumps Market Outlook, by Infusion Pumps, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Volumetric Infusion Pumps
      • 6.1.1.2. Insulin Infusion Pumps
      • 6.1.1.3. Syringe Infusion Pumps
      • 6.1.1.4. Enteral Infusion Pumps
      • 6.1.1.5. Ambulatory Infusion Pumps
      • 6.1.1.6. Patient-Controlled Analgesia Infusion Pumps
      • 6.1.1.7. Implantable Infusion Pumps
      • 6.1.1.8. Other Infusion Pumps Types
  • 6.2. Asia Pacific Intravenous Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Chemotherapy
      • 6.2.1.2. Diabetes
      • 6.2.1.3. Gastroenterology
      • 6.2.1.4. Analgesia/Pain Management
      • 6.2.1.5. Pediatrics /Neonatology
      • 6.2.1.6. Hematology
      • 6.2.1.7. Other Disease Indications
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Intravenous Infusion Pumps Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Intravenous Infusion Pumps Market Outlook, 2018 - 2031

  • 7.1. Latin America Intravenous Infusion Pumps Market Outlook, by Infusion Pumps, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Volumetric Infusion Pumps
      • 7.1.1.2. Insulin Infusion Pumps
      • 7.1.1.3. Syringe Infusion Pumps
      • 7.1.1.4. Enteral Infusion Pumps
      • 7.1.1.5. Ambulatory Infusion Pumps
      • 7.1.1.6. Patient-Controlled Analgesia Infusion Pumps
      • 7.1.1.7. Implantable Infusion Pumps
      • 7.1.1.8. Other Infusion Pumps Types
  • 7.2. Latin America Intravenous Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Chemotherapy
      • 7.2.1.2. Diabetes
      • 7.2.1.3. Gastroenterology
      • 7.2.1.4. Analgesia/Pain Management
      • 7.2.1.5. Pediatrics /Neonatology
      • 7.2.1.6. Hematology
      • 7.2.1.7. Other Disease Indications
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Intravenous Infusion Pumps Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Intravenous Infusion Pumps Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Intravenous Infusion Pumps Market Outlook, by Infusion Pumps, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Volumetric Infusion Pumps
      • 8.1.1.2. Insulin Infusion Pumps
      • 8.1.1.3. Syringe Infusion Pumps
      • 8.1.1.4. Enteral Infusion Pumps
      • 8.1.1.5. Ambulatory Infusion Pumps
      • 8.1.1.6. Patient-Controlled Analgesia Infusion Pumps
      • 8.1.1.7. Implantable Infusion Pumps
      • 8.1.1.8. Other Infusion Pumps Types
  • 8.2. Middle East & Africa Intravenous Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Chemotherapy
      • 8.2.1.2. Diabetes
      • 8.2.1.3. Gastroenterology
      • 8.2.1.4. Analgesia/Pain Management
      • 8.2.1.5. Pediatrics /Neonatology
      • 8.2.1.6. Hematology
      • 8.2.1.7. Other Disease Indications
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Intravenous Infusion Pumps Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Intravenous Infusion Pumps Market by Infusion Pumps, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Intravenous Infusion Pumps Market by Disease Indication, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Product vs by Disease Indication Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Baxter International
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Therapy Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. B. Braun Melsungen AG
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Therapy Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Medtronic
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Therapy Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Micrel Medical Devices SA
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Therapy Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Boston Scientific Corporation
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Therapy Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. CareFusion Corporation
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Therapy Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Fresenius Kabi
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Therapy Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Smith's Medical
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Therapy Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!